Low levels of sex hormone-binding globulin predict an increased breast cancer risk and its underlying molecular mechanisms.
Sex hormone-binding globulin (SHBG) is a serum glycoprotein exhibiting the unique feature of binding sex steroids with high affinity and specificity. Over the past few decades, there have be...